Travere Therapeutics, Inc., a biopharmaceutical company, identifies, develops, and delivers therapies to people living with rare kidney and metabolic diseases in the United States. The company's products include FILSPARI (sparsentan), a onc...
Leadership
Eric M. Dube Ph.D.
President, CEO & Director
Christopher Cline C.F.A.
Chief Financial Officer
William E. Rote Ph.D.
Chief Research Officer
Peter Heerma
Chief Commercial Officer
Jula Inrig M.D.
Executive VP, Head of Research & Development and Chief Medical Officer
Sandra Calvin
SVP & Chief Accounting Officer
Nivi Nehra
Vice President of Corporate Communications & Investor Relations
